680 related articles for article (PubMed ID: 19047290)
1. The International Neuroblastoma Risk Group (INRG) staging system: an INRG Task Force report.
Monclair T; Brodeur GM; Ambros PF; Brisse HJ; Cecchetto G; Holmes K; Kaneko M; London WB; Matthay KK; Nuchtern JG; von Schweinitz D; Simon T; Cohn SL; Pearson AD;
J Clin Oncol; 2009 Jan; 27(2):298-303. PubMed ID: 19047290
[TBL] [Abstract][Full Text] [Related]
2. The International Neuroblastoma Risk Group (INRG) classification system: an INRG Task Force report.
Cohn SL; Pearson AD; London WB; Monclair T; Ambros PF; Brodeur GM; Faldum A; Hero B; Iehara T; Machin D; Mosseri V; Simon T; Garaventa A; Castel V; Matthay KK;
J Clin Oncol; 2009 Jan; 27(2):289-97. PubMed ID: 19047291
[TBL] [Abstract][Full Text] [Related]
3. Neuroblastoma image-defined risk factors in adrenal neuroblastoma: role of radiologist.
Lanza C; Galeazzi V; Carboni N; De Berardinis A; De Marino L; Barile A; Giovagnoni A
Gland Surg; 2019 Sep; 8(Suppl 3):S168-S177. PubMed ID: 31559184
[TBL] [Abstract][Full Text] [Related]
4. Association of image-defined risk factors with clinical features, tumor biology, and outcomes in neuroblastoma: a single-center retrospective study.
Yang DD; Liu C; Gao J; Hu QJ; Liang Y; Liu J
Eur J Pediatr; 2023 May; 182(5):2189-2196. PubMed ID: 36856889
[TBL] [Abstract][Full Text] [Related]
5. A review of neuroblastoma image-defined risk factors on magnetic resonance imaging.
Chen AM; Trout AT; Towbin AJ
Pediatr Radiol; 2018 Aug; 48(9):1337-1347. PubMed ID: 30078048
[TBL] [Abstract][Full Text] [Related]
6. Image-defined risk factors in localized thoracic neuroblastoma and ganglioneuroma.
Butzer SK; Krug B; Reisberg M; Fuchs J; Warmann SW; Hubertus J; Körber F; Berthold F; Simon T; Hero B
Pediatr Blood Cancer; 2023 Oct; 70(10):e30605. PubMed ID: 37534915
[TBL] [Abstract][Full Text] [Related]
7. Imaging neuroblastoma: what the radiologist needs to know.
McCarville MB
Cancer Imaging; 2011 Oct; 11 Spec No A(1A):S44-7. PubMed ID: 22187096
[TBL] [Abstract][Full Text] [Related]
8. Image-defined Risk Factors Correlate with Surgical Radicality and Local Recurrence in Patients with Neuroblastoma.
Pohl A; Erichsen M; Stehr M; Hubertus J; Bergmann F; Kammer B; von Schweinitz D
Klin Padiatr; 2016 Apr; 228(3):118-23. PubMed ID: 26930233
[TBL] [Abstract][Full Text] [Related]
9. The Dramatic Consequences of an Accidental Ligation of the Celiac Trunk during Surgery Performed on a Child with Neuroblastoma.
Sosnowska-Sienkiewicz P; Januszkiewicz-Lewandowska D; Mańkowski P
Int J Environ Res Public Health; 2021 Feb; 18(4):. PubMed ID: 33672809
[TBL] [Abstract][Full Text] [Related]
10. Guidelines for imaging and staging of neuroblastic tumors: consensus report from the International Neuroblastoma Risk Group Project.
Brisse HJ; McCarville MB; Granata C; Krug KB; Wootton-Gorges SL; Kanegawa K; Giammarile F; Schmidt M; Shulkin BL; Matthay KK; Lewington VJ; Sarnacki S; Hero B; Kaneko M; London WB; Pearson AD; Cohn SL; Monclair T;
Radiology; 2011 Oct; 261(1):243-57. PubMed ID: 21586679
[TBL] [Abstract][Full Text] [Related]
11. Revised Neuroblastoma Risk Classification System: A Report From the Children's Oncology Group.
Irwin MS; Naranjo A; Zhang FF; Cohn SL; London WB; Gastier-Foster JM; Ramirez NC; Pfau R; Reshmi S; Wagner E; Nuchtern J; Asgharzadeh S; Shimada H; Maris JM; Bagatell R; Park JR; Hogarty MD
J Clin Oncol; 2021 Oct; 39(29):3229-3241. PubMed ID: 34319759
[TBL] [Abstract][Full Text] [Related]
12. Statistical Framework in Support of a Revised Children's Oncology Group Neuroblastoma Risk Classification System.
Naranjo A; Irwin MS; Hogarty MD; Cohn SL; Park JR; London WB
JCO Clin Cancer Inform; 2018 Dec; 2():1-15. PubMed ID: 30652588
[TBL] [Abstract][Full Text] [Related]
13. Tailoring Therapy for Children With Neuroblastoma on the Basis of Risk Group Classification: Past, Present, and Future.
Liang WH; Federico SM; London WB; Naranjo A; Irwin MS; Volchenboum SL; Cohn SL
JCO Clin Cancer Inform; 2020 Oct; 4():895-905. PubMed ID: 33058692
[TBL] [Abstract][Full Text] [Related]
14. Bilateral adrenal neuroblastoma in the infant: Is it an image-defined risk factor?
Marino S; La Spina M; Scuderi MG; Di Benedetto V; Magro G; Belfiore G; Coronella M; D'Amico S; Lo Nigro L; Russo G; Di Cataldo A
Pediatr Hematol Oncol; 2016 May; 33(4):259-63. PubMed ID: 27285992
[TBL] [Abstract][Full Text] [Related]
15. Image-defined risk factor assessment of neurogenic tumors after neoadjuvant chemotherapy is useful for predicting intra-operative risk factors and the completeness of resection.
Irtan S; Brisse HJ; Minard-Colin V; Schleiermacher G; Galmiche-Rolland L; Le Cossec C; Elie C; Canale S; Michon J; Valteau-Couanet D; Sarnacki S
Pediatr Blood Cancer; 2015 Sep; 62(9):1543-9. PubMed ID: 25820608
[TBL] [Abstract][Full Text] [Related]
16. How well do image-defined risk factors (IDRFs) predict surgical outcomes and survival in patients with neuroblastoma? A systematic review and meta-analysis.
Parhar D; Joharifard S; Lo AC; Schlosser MP; Daodu OO
Pediatr Surg Int; 2020 Aug; 36(8):897-907. PubMed ID: 32533235
[TBL] [Abstract][Full Text] [Related]
17.
Bhardwaj N; Rohilla M; Trehan A; Bansal D; Kakkar N; Srinivasan R
J Clin Pathol; 2023 Sep; 76(9):599-605. PubMed ID: 35414524
[TBL] [Abstract][Full Text] [Related]
18. Criteria for evaluation of disease extent by (123)I-metaiodobenzylguanidine scans in neuroblastoma: a report for the International Neuroblastoma Risk Group (INRG) Task Force.
Matthay KK; Shulkin B; Ladenstein R; Michon J; Giammarile F; Lewington V; Pearson AD; Cohn SL
Br J Cancer; 2010 Apr; 102(9):1319-26. PubMed ID: 20424613
[TBL] [Abstract][Full Text] [Related]
19. Influence of image-defined risk factors on the outcome of patients with localised neuroblastoma. A report from the LNESG1 study of the European International Society of Paediatric Oncology Neuroblastoma Group.
Monclair T; Mosseri V; Cecchetto G; De Bernardi B; Michon J; Holmes K
Pediatr Blood Cancer; 2015 Sep; 62(9):1536-42. PubMed ID: 25663103
[TBL] [Abstract][Full Text] [Related]
20. Prognostic value of the stage 4S metastatic pattern and tumor biology in patients with metastatic neuroblastoma diagnosed between birth and 18 months of age.
Taggart DR; London WB; Schmidt ML; DuBois SG; Monclair TF; Nakagawara A; De Bernardi B; Ambros PF; Pearson AD; Cohn SL; Matthay KK
J Clin Oncol; 2011 Nov; 29(33):4358-64. PubMed ID: 21969516
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
